Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIPEL.L Regulatory News (IPEL)

  • There is currently no data for IPEL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Nominated Adviser and Sole Broker

6 Feb 2020 07:00

RNS Number : 1254C
Impellam Group plc
06 February 2020
 

6 February 2020

Impellam Group plc

("Impellam" or the "Company")

Appointment of Nominated Adviser and Sole Broker

Impellam (AIM: IPEL) is pleased to announce the appointment of Canaccord Genuity Limited ("Canaccord") as Nominated Adviser and Sole Broker to Impellam with immediate effect.

Further to the above and the announcement made on 22 August 2018 by the Company regarding the Share Purchase Plan, Canaccord will take over the coordination of the Company's share buy-back programme effective today, 6 February 2020.

Under the Share Purchase Plan, the Company have instructed Canaccord to acquire ordinary shares of 1p each in the capital of the Company ("Ordinary Shares") for cancellation. The maximum price paid for such Ordinary Shares shall be an amount equal to the higher of (i) 5% above the average of the middle market quotations for the Ordinary Shares for the five business days prior to making any purchase; and (ii) the higher of the price of the last independent trade of and the highest current independent bid for an Ordinary Share on the London Stock Exchange's AIM market.

Since 11 October 2019, when the Company commenced further share purchases under its renewed Share Purchase Plan, the Company has purchased 1,191,500 Ordinary Shares under the Share Purchase Plan, at an approximate cost of £4.40 million. As at 31 January 2020, the number of Ordinary Shares in issue and admitted to trading on AIM is 46,811,160. This figure of 46,811,160 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Notwithstanding the average daily volume restrictions set out in Article 3(3) (b) of the Commission Delegated Regulation (EU) 2016/1052, the Company may make purchases in excess of these volume restrictions, subject to prevailing market conditions and liquidity.

Enquiries:

Impellam Group plc

Julia Robertson, Chief Executive Officer

 

01582 692 658

Canaccord Genuity Ltd (Nomad and Sole Broker)

Bobbie Hilliam

Georgina McCooke

 

020 7523 8150

 

Note to Editors:

Impellam is the second largest1 staffing company in the UK and sixth largest2 Managed Services provider worldwide. Our vision is to be the world's most trusted staffing company - trusted by our people, our customers and our investors in equal measure.

We provide Managed Services and Specialist Staffing solutions across the UK, Europe, US, the Middle East and Australasia. We have over 3,200 Impellam people throughout our network of 17 market-leading brands across 165 worldwide locations.

Ultimately, Impellam Group's mission is to provide fulfilment and a sense of purpose to our people and to help customers build better businesses in a changing world.

For more information about Impellam Group please visit: www.impellam.com 

By revenue (2017 published numbers)

2 By SUM (confirmed by Staffing Industry Analysts. Spend Under Management (SUM) is the total amount of client expenditure which our Managed Services brands manage on behalf of their clients. This equates to revenue earned where Impellam acts as principal plus gross billings to customers where Impellam acts as agent (2017 published numbers). Management use this measure as it reflects the total value of the client spend to the Group and not just the revenue generated

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
APPBIGDDUSGDGGU
Date   Source Headline
24th Sep 20195:47 pmRNSTransaction in Own Shares
19th Sep 20199:39 amRNSTransaction in Own Shares
23rd Aug 20194:46 pmRNSTransaction in Own Shares
8th Aug 20197:00 amRNSTransaction in Own Shares
30th Jul 20197:00 amRNSHalf-year Report
15th Jul 20197:00 amRNSTransaction in Own Shares
9th Jul 20197:00 amRNSAcquisition of AI Powered Staffing Platform
26th Jun 20199:51 amRNSResult of AGM
25th Jun 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Jun 20197:00 amRNSTransaction in Own Shares
24th May 20194:50 pmRNSTransaction in Own Shares
8th May 20194:50 pmRNSTransaction in Own Shares
24th Apr 20193:59 pmRNSTransaction in Own Shares
28th Mar 20197:00 amRNSTransaction in Own Shares
21st Mar 20199:00 amRNSPreliminary Results: Correction
21st Mar 20197:00 amRNSTransaction in Own Shares
14th Mar 20197:00 amRNSPreliminary Results - Unaudited
13th Mar 20195:41 pmRNSTransaction in Own Shares
28th Feb 20197:00 amRNSTransaction in Own Shares
20th Feb 20197:00 amRNSDemerger of Carlisle Support Services
14th Feb 20194:21 pmRNSTransaction in Own Shares and Total Voting Rights
14th Jan 20194:29 pmRNSTransaction in Own Shares
21st Dec 20184:18 pmRNSTransaction in Own Shares
5th Dec 20185:02 pmRNSTransaction in Own Shares
14th Nov 20183:36 pmRNSTransaction in Own Shares & Total Voting Rights
13th Nov 20183:04 pmRNSTransaction in Own Shares
8th Nov 20187:00 amRNSTransaction in Own Shares
31st Oct 20187:00 amRNSTransaction in Own Shares
15th Oct 20187:00 amRNSTransaction in Own Shares
8th Oct 20187:00 amRNSTransaction in Own Shares
27th Sep 20185:21 pmRNSTransaction in Own Shares
27th Sep 20184:41 pmRNSSecond Price Monitoring Extn
27th Sep 20184:35 pmRNSPrice Monitoring Extension
27th Sep 20187:00 amRNSDirectorate Change
27th Sep 20187:00 amRNSTrading Statement
22nd Aug 201812:51 pmRNSTransaction in Own Shares
26th Jul 20187:00 amRNSHalf-year Report
21st Jun 201810:05 amRNSResult of AGM
5th Jun 20184:47 pmRNSTransaction in Own Shares and Total Voting Rights
31st May 20187:00 amRNSDirectorate Change
10th May 201812:14 pmRNSTransaction in Own Shares and Total Voting Rights
24th Apr 20186:23 pmRNSHolding(s) in Company
24th Apr 20183:02 pmRNSTransaction in Own Shares and Total Voting Rights
21st Mar 20187:00 amRNSTransaction in Own Shares
20th Mar 20185:17 pmRNSHolding(s) in Company
20th Mar 20185:14 pmRNSDirector/PDMR Shareholding
16th Mar 201810:12 amRNSAnnual Financial Report
8th Mar 20187:00 amRNSPreliminary Results - Unaudited
19th Feb 20183:22 pmRNSTransaction in Own Shares and Total Voting Rights
15th Jan 20184:47 pmRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.